BioAtla, Inc.
SIMULTANEOUS, INTEGRATED SELECTION AND EVOLUTION OF ANTIBODY/PROTEIN PERFORMANCE AND EXPRESSION IN PRODUCTION HOSTS
Last updated:
Abstract:
The present disclosure provides methods of integrating therapeutic protein and antibody generation and/or selection, evolution and expression in a eukaryotic host for manufacturing in a single system. Therapeutic proteins, including antibodies, are generated, optimized and manufactured in the same eukaryotic host system. The disclosed system of Comprehensive Integrated Antibody Optimization (CIAO!.TM.) allows for simultaneous evolution of protein performance and expression optimization.
Status:
Application
Type:
Utility
Filling date:
27 Jan 2021
Issue date:
8 Jul 2021